Plus, news about Annexon, Passkey Therapeutics, XOMA Royalty and Twist Bioscience:
MacroGenics sells breast cancer drug rights for up to $75 million: The company is …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.